Simmi Wiggins
Reading, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Correction: Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria.
Journal: Dermatology and therapy
Published: March 19, 2026
Dupilumab subgroup responder analysis: a post hoc analysis from LIBERTY PRIME and PRIME2 in prurigo nodularis.
Journal: The Journal of dermatological treatment
Published: March 11, 2026
Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis.
Journal: Dermatology and therapy
Published: March 03, 2026
The evolving understanding of prurigo nodularis.
Journal: Clinical and experimental dermatology
Published: February 02, 2026
Dupilumab in moderate-to-severe prurigo nodularis: Real-world data from early access program.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 14, 2025
Dupilumab Improves Prurigo Activity and Severity in Patients with Prurigo Nodularis: A Post Hoc Analysis of Pooled Results from the PRIME and PRIME2 Trials.
Journal: Dermatology and therapy
Published: October 29, 2025
Standardizing Prurigo Control Assessment Globally: Linguistic Validation and Cross-cultural Adaptation of Prurigo Control Test in 18 Languages.
Journal: Acta dermato-venereologica
Published: October 22, 2025
Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies.
Journal: Dermatology and therapy
Published: October 22, 2025
Clinical perspectives on prurigo nodularis: diagnostic challenges and novel treatment options.
Journal: Italian journal of dermatology and venereology
Published: September 10, 2025
Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria.
Journal: Dermatology and therapy
Published: August 26, 2025
Efficacy and Safety of Dupilumab in Adults with Prurigo Nodularis with or Without Atopic Comorbidities: A Subgroup Analysis from Two Randomized Phase III Clinical Trials.
Journal: American journal of clinical dermatology
Published: June 06, 2025
Prurigo nodularis: disease burden, clinical features and approach to management.
Journal: The British journal of dermatology
Published: December 04, 2024
Last Updated: 09/26/2026